Premium
Valvular heart disease in a patient taking 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’)
Author(s) -
Montastruc François,
Montastruc Guillaume,
Vigreux Philippe,
Bruneval Patrick,
GuilbeauFrugier Céline,
Cron Christophe,
Bagheri Haleh,
Delisle Bernadette,
LapeyreMestre Maryse,
Pathak Atul,
Montastruc JeanLouis
Publication year - 2012
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.2012.04252.x
Subject(s) - cardiology , medicine , ecstasy , mitral regurgitation , ejection fraction , mitral valve , mitral valve prolapse , chest pain , sinus rhythm , valvular heart disease , heart failure , atrial fibrillation , psychiatry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom